Companies
Health Care
851 companies, ranked by market cap.
| Company | Sector | Market cap β | Price | Day | Revenue | Growth | Op. margin | P/E |
|---|---|---|---|---|---|---|---|---|
| KALA BIO, Inc.KALA | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $0.0M | β | β | β |
| Cadrenal Therapeutics, Inc.CVKD | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | β | β | β | β |
| Jupiter Neurosciences, Inc.JUNS | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | $0.0M | β | β40,865.6% | β |
| Ernexa Therapeutics Inc.ERNA | Pharmaceutical Preparations | β | β | οΏ½οΏ½ | β | β | β | β |
| Editas Medicine, Inc.EDIT | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $40.5M | 25.4% | β394.9% | β |
| Novavax IncNVAX | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $1.1B | 64.7% | 40.3% | β |
| Maze Therapeutics, Inc.MAZE | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | β | β | β | β |
| Vir Biotechnology, Inc.VIR | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $68.6M | β7.6% | β699.2% | β |
| Immunocore Holdings plcIMCR | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $400M | 29.0% | β11.3% | β |
| Mesoblast LtdMESO | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $120M | 599.2% | β | β |
| Inhibrx Biosciences, Inc.INBX | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $1.3M | 550.0% | β10,386.5% | β |
| Taysha Gene Therapies, Inc.TSHA | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $9.8M | 17.3% | β1,130.6% | β |
| Immatics N.V.IMTX | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | β | β | β | β |
| Vor Biopharma Inc.VOR | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | β | β | β | β |
| Replimune Group, Inc.REPL | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | β | β | β | β |
| Monte Rosa Therapeutics, Inc.GLUE | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $124M | 63.5% | β43.8% | β |
| MeiraGTx Holdings plcMGTX | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $81.4M | 144.6% | β130.2% | β |
| Cullinan Therapeutics, Inc.CGEM | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | β | β | β | β |
| 4D Molecular Therapeutics, Inc.FDMT | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $85.2M | 230,194.6% | β187.2% | β |
| Prime Medicine, Inc.PRME | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $4.6M | 55.3% | β4,498.1% | β |
| Sana Biotechnology, Inc.SANA | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | β | β | β | β |
| Solid Biosciences Inc.SLDB | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | β | β | β | β |
| Aura Biosciences, Inc.AURA | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $6.6M | β29.7% | β1,701.0% | β |
| Ginkgo Bioworks Holdings, Inc.DNA | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $170M | β25.1% | β185.3% | β |
| Candel Therapeutics, Inc.CADL | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | β | β | β | β |
| DBV Technologies S.A.DBVT | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $5.6M | 35.8% | β2,609.2% | β |
| Prokidney Corp.PROK | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $0.9M | 1,075.0% | β18,477.8% | β |
| Entera Bio Ltd.ENTX | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $0.0M | β76.8% | β27,450.0% | β |
| REGENXBIO Inc.RGNX | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $170M | 104.5% | β94.6% | β |
| Allogene Therapeutics, Inc.ALLO | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $0.0M | β100.0% | β | β |
| Autolus Therapeutics plcAUTL | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $75.4M | 644.9% | β358.9% | β |
| Tectonic Therapeutic, Inc.TECX | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | β | β | β | β |
| C4 Therapeutics, Inc.CCCC | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $35.9M | 1.0% | β320.5% | β |
| Zura Bio LtdZURA | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | β | β | β | β |
| Lineage Cell Therapeutics, Inc.LCTX | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $14.6M | 53.2% | β251.6% | β |
| Voyager Therapeutics, Inc.VYGR | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $40.4M | β49.5% | β326.6% | β |
| Anavex Life Sciences Corp.AVXL | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $4.7M | β36.1% | β1,098.9% | β |
| Outlook Therapeutics, Inc.OTLK | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $1.4M | β | β4,744.4% | β |
| Compass Therapeutics, Inc.CMPX | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $0.0M | β100.0% | β | β |
| Acumen Pharmaceuticals, Inc.ABOS | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | β | β | β | β |
| Protara Therapeutics, Inc.TARA | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | β | β | β | β |
| Coherus Oncology, Inc.CHRS | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $42.2M | 59.8% | β429.5% | β |
| Sutro Biopharma, Inc.STRO | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $102M | 65.2% | β154.5% | β |
| Precision Biosciences IncDTIL | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $34.3M | β50.1% | β152.2% | β |
| Alpha Cognition Inc.ACOG | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $10.2M | β | β221.7% | β |
| Invivyd, Inc.IVVD | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $53.4M | 110.5% | β104.0% | β |
| Protalix BioTherapeutics, Inc.PLX | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $52.7M | β1.2% | β10.4% | β |
| Alector, Inc.ALEC | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $21.0M | β79.1% | β741.3% | β |
| Inhibikase Therapeutics, Inc.IKT | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $3.7M | β | β1,399.0% | β |
| Surrozen, Inc./DESRZN | Biological Products, (No Diagnostic Substances) | β | β | οΏ½οΏ½ | $3.5M | β67.4% | β1,210.6% | β |